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C. Kofman1, A. Teper1. 1Ricardo Gutie´rrez Children’s Hospital, Respiratory
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CF is the most common genetic lethal disorder in Caucasian population. Chronic
colonization with Pseudomonas aeruginosa (PA) and with Burkholderia cepacia
complex (Bcc) show more rapidly decline in pulmonary function and a decrease in
survival. The aim of the study was to compare the pulmonary function and clinical
characteristics of CF patients with and without chronic colonization with (Bcc).
Methods: In an observational cross-sectional study, we collected data from CF pa-
tients chronically infected with Bcc (more than 50% of sputum cultures positive)
and without Bcc (never positive), matched for age and pancreatic sufﬁciency in a
1:4 fashion, that were evaluated through sputum culture at least four times at the
Respiratory Center from December 2008 to December 2009. We considered: current
age, age at diagnosis, genetics, PA colonization, pulmonary function, nutritional
status and respiratory exacerbations (needs of intravenous antibiotics).
Results: We included 7 patients (8.15±3.8) years chronically infected with Bcc,
and 28 control patients (8.12±3.5) years (NS). Median Age at diagnosis were 0.16
(0.08 to 4) and 0.27 (0.11 to 12.24) (NS); p.F508del homozygous were 85% and
68% (NS); PA colonization were 28% and 32% (NS); median Zscore BMI were
−0.37 (−0.51 to 0.09) and −0.18 (−0.69 to 0.36) (NS), for Bcc and non Bcc groups
respectively. FEV1 was 51±18.8 and 88±27.6 (p< 0.05) and number of respiratory
exacerbations were 2±0.81 and 0.5±0.32 (p< 0.05) for Bcc and non Bcc groups
respectively.
Conclusion: Chronic infection with Burkholderia cepacia complex determined a
lower pulmonary function and more respiratory exacerbations in CF patients.
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Objectives: Our aim was to study the role of Aspergillus Fumigatus (AF) colo-
nization in CF patients. We compared the impact of AF colonization with that of
ABPA on lung injury evolution. The association between AF and Pseudomonas
aeruginosa (PA) infection in CF patients was also investigated.
Methods: This was a retrospective cohort study of CF patients followed at the
Bambino Gesu` Hospital from January 1998 and August 2009. 52 patients were
deﬁned affected by AF according to the following criteria: two or more positive
sputum and speciﬁc RAST levels >0.5UI/ml. These patients were then divided
in two subgroups: group AF colonization (n = 36), characterized by two or more
positive sputum for AF; group ABPA (n = 16) with a compatible clinical picture and
radiological signs, positive speciﬁc RAST and total serum IgE levels >500UI/ml.
We compared this two groups with a control group including 52 patients. We
considered FeV1 values to evaluate lung injury. 104 CF patients were included in
the analysis. Mean FeV1 was signiﬁcantly lower in the two groups affected by AF
infection (AF 69.9±19.6; ABPA 71.5±25.1) than in the control group (91.9±22.1;
p< 0.0001), without any signiﬁcant difference between group AF and group ABPA
(p = 0.78). The univariate and multivariate regression analysis showed that both
the infection by AF and by PA were associated with lower FeV1 values, and this
association was stronger for AF.
Conclusion: Our data demonstrate that the presence of AF in CF patients is
associated with lower FeV1 values independently by the development of ABPA.
The role of AF infection on lung injury seems to be even stronger than those
played by PA.
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Background: Annual inﬂuenza vaccination is recommended for risk-groups, in-
cluding CF-patients. However inﬂuenza vaccine efﬁcacy in CF is not well docu-
mented.
Aims: To evaluate the impact of inﬂuenza infection in well-vaccinated CF-patients.
Methods: During 4 winter seasons, we prospectively collected nasal secretions
by nasal wash for PCR and culture and/or blood for serology, for detection of
respiratory viruses in correctly* against inﬂuenza vaccinated CF-patients with an
acute pulmonary exacerbation.
Results: Inﬂuenza viruses were detected in a total of 21/170 (12.4%) acute
pulmonary exacerbations in 75 CF-patients (median age = 17 y7m; gender ratio:
F/M= 38/37). Inﬂuenza A was found in 19 and inﬂuenza B in 2 episodes. In 13/19
inﬂuenza A and 1/2 inﬂuenza B infections the patient had fever (>38.5ºC) and
in 8/19 inﬂuenza A infections the patient needed oxygen suppletion. For 17/21
inﬂuenza infections hospitalisation was necessary with a mean stay of 11.7 days.
Conclusions: Inﬂuenza infection is frequent in CF-patients, especially in adoles-
cents and adults, despite correct vaccination. Inﬂuenza in CF-patients is associated
with a high rate of oxygen need and prolonged hospitalisation.
*according to ACIP recommendations. A. Malfroot, E. De Wachter, D. Pierard, S.
Lauwers. J of Cystic Fibrosis 2005; 4 (suppl).
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Background: During the inﬂuenza A/H1N1v (A/H1N1) pandemic, CF patients
(pts) were considered at risk for severe complications, as for seasonal ﬂu. Data on
the real impact of A/H1N1 in CF are scarce.
Aims: To evaluate the impact of A/H1N1 infection in our CF clinic (150 pts) during
the Belgian pandemic Oct−Dec 2009, compared to other risk groups, and to the
impact of seasonal ﬂu in previous years.
Methods: In all CF pts presenting during the pandemic with fever or pulmonary
exacerbation, we collected nasal secretions for PCR and culture and/or blood for
serology, to detect respiratory viruses including A/H1N1. All CF pts are annually
correctly vaccinated against seasonal inﬂuenza.
Results: A/H1N1 was detected in 15 CF pts (9 aged 0−15 yrs, 4 adolescents and
2 above 18 yrs), in 15 (non CF) children with neurodevelopment disease (NDD), and
in 79 healthy children. 12/15 CF pts received oseltamivir, which was well tolerated,
10/15 received antibiotics of which 4/10 intravenously. Only one 9 yrs old CF-girl
had permanent respiratory decline with chronic hypoxemia. In our previous seasonal
inﬂuenza survey 17/21 CF pts were hospitalised and 8 had prolonged oxygen need.
In NDD pts A/H1N1 led in 3/15 to lethal respiratory complications (SARI) and
in 1/15 to lobectomy. 24/79 healthy children had bacterial pneumonia without any
permanent sequelae.
Conclusions: Chronic respiratory disease and NDD are considered as risk factors
for complicated A/H1N1infection. Our data suggest that A/H1N1 may be less
dangerous in CF than seasonal inﬂuenza A despite seasonal vaccination. CF pts
seem less at risk compared to NDD pts. Vaccination of vulnerable groups remains
crucial.
